BioSpace News Archive

The C3i Center (C3i) is proud to announce the participation of AstraZeneca Canada (AstraZeneca) in supporting the development of the Lymphoma Registry.

Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, today announced it discovered a novel genetic biomarker, Denovo Genomic Marker 7 (DGM7 TM), using its proprietary biomarker discovery platform.

City of Hope doctors presented data on an investigational bispecific antibody for multiple myeloma and the CMVPepVax, a City of Hope-developed vaccine against the cytomegalovirus, at this year’s ASH Annual Meeting.

Vero Diagnostics, a CLIA high complexity & CAP certified, state-of-the-art laboratory, announced the launch of the Baebies® FINDER® 1.5 ultra-rapid SARS-CoV-2 RT-PCR testing platform to Vero Diagnostics customers in Los Angeles.

AstraZeneca’s EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron SARS-CoV-2 variant (B.1.1.529), according to new preclinical data.

Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), stating that PAXLOVID can be used to treat adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease.

“We are very pleased with our manufacturing partner Ausun for reaching this milestone as this is a significant step forward in moving towards clinical trials,” said Rod Matheson, Chief Executive Officer.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company’s partner in China, Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), received approval from the National Medical Products Administration (NMPA) of China of NUZYRA® (omadacycline) for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

HealthTrackRx, the leading polymerase chain reaction (PCR) testing lab, provides clinicians with a menu of respiratory testing solutions focused on diagnostic speed and accuracy.

Zogenix announced that the compensation committee of the company’s board of directors granted inducement awards to nine new non-executive employees.